Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT02730195
Title Pioglitazone and Tyrosine Kinase Inhibitor in Treating Patients With Relapsed Chronic Myeloid Leukemia
Recruitment Terminated
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors Emory University
Indications
Therapies
Age Groups: adult | child
Covered Countries USA

Additional content available in CKB BOOST